Download Characterization of disease-causing dendritic cells in Crohn`s

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Ulcerative colitis wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Periodontal disease wikipedia , lookup

Crohn's disease wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Neuromyelitis optica wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Innate immune system wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Ankylosing spondylitis wikipedia , lookup

Pathophysiology of multiple sclerosis wikipedia , lookup

Inflammation wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Multiple sclerosis signs and symptoms wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Immunomics wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Inflammatory bowel disease wikipedia , lookup

Transcript
M.Sarfati CCFC 2010
Project Title: Characterization of disease-causing dendritic cells in Crohn's disease
Lay Summary:
Crohn’s disease (CD) is a chronic inflammatory intestinal disorder with no known cure. The
inflammation characteristic of CD can be found anywhere along the digestive tract, and is thought
to result from an inappropriate immune response in genetically-prone individuals. Its incidence is
rising in Canada, where its prevalence is said to be among the highest in the world. CD patients
experience severe symptoms such as abdominal pain, nausea/vomiting and diarrhea. The
currently available therapies for CD are often associated with serious side effects and highlight the
need for continued research in this field.
Dendritic cells (DCs) are a specialized cell type primarily located within tissues that are in contact
with the external environment, such as the gut. They participate in discriminating between
harmful and harmless external threats. Therefore, when dysregulated, DCs may misinterpret a
harmless encounter and initiate an immune response, leading to chronic intestinal inflammation.
We recently identified a subset of DCs (SIRP-α+ DCs), which promote intestinal inflammation in a
mouse model of CD. Therefore, the identification of the human counterpart of SIRPα+ DCs in mice
may contribute to our knowledge of the development of IBD. The purpose of this study is to
characterize these DCs in human intestinal tissue of CD and healthy patients. The study will also
compare the function of these DCs in blood and those isolated from intestinal tissues. Other than
extending our scientific knowledge of IBD, this work may translate into the development of new
therapeutic targets for IBD patients.